Compare DexCom, Inc. (DXCM) vs Fiverr International Ltd (FVRR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Fiverr International Ltd — how do they compare? DexCom, Inc. trades at $77.34 (market cap $28.06B), while Fiverr International Ltd trades at $11.82 (market cap $404.45M). The key difference: DexCom, Inc. is far larger — about 69.4× Fiverr International Ltd's market cap, and DexCom, Inc. is trading nearer its 52-week high, Fiverr International Ltd nearer its low. Which is the better fit depends on your goals.
| DXCM | FVRR | |
|---|---|---|
Market Cap | $28.06B | $404.45M |
Sector | Health | Industrials |
52-Week High | $89.53 | $26.67 |
52-Week Low | $54.84 | $9.62 |
Enterprise Value | $27.03B | $135.05M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
Fiverr International (FVRR) trades at $11.07, down 1.77% on the day, with a bullish technical signal from moving averages. The company reported revenue of $430.91M in 2025, with net income of $20.98M and improving profit margins. Recent earnings show a mix of beats and one miss, with Q2 2026 results expected soon. Analyst sentiment is mixed, with 41.18% buy ratings and no sell ratings.
The outlook hinges on execution of its strategy shift amid competitive pressures. Risks include declining active buyers and a pending legal investigation. Upside potential exists if spending per buyer growth continues and the company returns to consistent earnings beats, but investor caution is warranted near the 52-week low.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →
